NewGenIvf Group Limited
NIVF · NASDAQ
9/30/2025 | 12/31/2024 | 9/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.42 | 0.00 | -3.54 |
| FCF Yield | 0.00% | -13.79% | 0.00% | -0.03% |
| EV / EBITDA | 0.31 | 834.64 | 174.36 | 1,224.77 |
| Quality | ||||
| ROIC | -7.34% | -6.41% | -11.99% | -35.38% |
| Gross Margin | 9.20% | 28.21% | 43.87% | 12.95% |
| Cash Conversion Ratio | 58.70 | 0.15 | -1.60 | -0.07 |
| Growth | ||||
| Revenue 3-Year CAGR | 1,770,269.44% | 1,621,793.71% | 1,440,939.47% | 1,149,541.98% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 29.80% |
| Safety | ||||
| Net Debt / EBITDA | 0.31 | 44.10 | 22.48 | 0.62 |
| Interest Coverage | -52.24 | -2.59 | 0.87 | -50.12 |
| Efficiency | ||||
| Inventory Turnover | 13.39 | 11.31 | 3.46 | 10.48 |
| Cash Conversion Cycle | 120.50 | -23.67 | -178.17 | 27.62 |